FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2463341441> ?p ?o ?g. }

• W2463341441 endingPage "49026" @default.
• W2463341441 startingPage "49008" @default.
• W2463341441 abstract "Interleukin-15 (IL-15) is a cell growth-factor that regulates lymphocyte function and homeostasis. Its strong immunostimulatory activity coupled with an apparent lack of toxicity makes IL-15 an exciting candidate for cancer therapy, somehow limited by its short half-life in circulation. To increase IL-15 bioavailability we constructed a recombinant adeno-associated vector expressing murine IL-15 (AAV-mIL15) in the liver. Mice injected with AAV-mIL15 showed sustained and vector dose-dependent levels of IL-15/IL-15Rα complexes in serum, production of IFN-γ and activation of CD8+ T-cells and macrophages. The antitumoral efficacy of AAV-mIL15 was tested in a mouse model of metastatic colorectal cancer established by injection of MC38 cells. AAV-mIL15 treatment slightly inhibits MC38 tumor-growth and significantly increases the survival of mice. However, mIL-15 sustained expression was associated with development of side effects like hepatosplenomegaly, liver damage and the development of haematological stress, which results in the expansion of hematopoietic precursors in the bone marrow. To elucidate the mechanism, we treated IFN-γ receptor-, RAG1-, CD1d- and µMT-deficient mice and performed adoptive transfer of bone marrow cells from WT mice to RAG1-defcient mice. We demonstrated that the side effects of murine IL-15 administration were mainly mediated by IFN-γ-producing T-cells.IL-15 induces the activation and survival of effector immune cells that are necessary for its antitumoral activity; but, long-term exposure to IL-15 is associated with the development of important side effects mainly mediated by IFN-γ-producing T-cells. Strategies to modulate T-cell activation should be combined with IL-15 administration to reduce secondary adverse events while maintaining its antitumoral effect." @default.
• W2463341441 created "2016-07-22" @default.
• W2463341441 creator A5011351945 @default.
• W2463341441 creator A5011904150 @default.
• W2463341441 creator A5044943938 @default.
• W2463341441 creator A5047696571 @default.
• W2463341441 creator A5054743810 @default.
• W2463341441 creator A5068667427 @default.
• W2463341441 creator A5069905573 @default.
• W2463341441 creator A5074495073 @default.
• W2463341441 date "2016-06-23" @default.
• W2463341441 modified "2023-10-14" @default.
• W2463341441 title "Identification of IFN-γ-producing T cells as the main mediators of the side effects associated to mouse interleukin-15 sustained exposure" @default.
• W2463341441 cites W1487210663 @default.
• W2463341441 cites W1491154613 @default.
• W2463341441 cites W1495421840 @default.
• W2463341441 cites W1505315838 @default.
• W2463341441 cites W1506949828 @default.
• W2463341441 cites W1846959033 @default.
• W2463341441 cites W1879871130 @default.
• W2463341441 cites W1963991141 @default.
• W2463341441 cites W1975047479 @default.
• W2463341441 cites W1977727186 @default.
• W2463341441 cites W1987128447 @default.
• W2463341441 cites W1990991590 @default.
• W2463341441 cites W1998887003 @default.
• W2463341441 cites W2006073656 @default.
• W2463341441 cites W2012868337 @default.
• W2463341441 cites W2012894204 @default.
• W2463341441 cites W2020313517 @default.
• W2463341441 cites W2024043434 @default.
• W2463341441 cites W2025418275 @default.
• W2463341441 cites W2028345258 @default.
• W2463341441 cites W2032817241 @default.
• W2463341441 cites W2037070751 @default.
• W2463341441 cites W2058860008 @default.
• W2463341441 cites W2060928633 @default.
• W2463341441 cites W2068871282 @default.
• W2463341441 cites W2069486064 @default.
• W2463341441 cites W2070770310 @default.
• W2463341441 cites W2072411272 @default.
• W2463341441 cites W2075293216 @default.
• W2463341441 cites W2078403452 @default.
• W2463341441 cites W2080480755 @default.
• W2463341441 cites W2084293527 @default.
• W2463341441 cites W2085965038 @default.
• W2463341441 cites W2089456457 @default.
• W2463341441 cites W2095138364 @default.
• W2463341441 cites W2097250838 @default.
• W2463341441 cites W2098930115 @default.
• W2463341441 cites W2100543114 @default.
• W2463341441 cites W2105746374 @default.
• W2463341441 cites W2116369307 @default.
• W2463341441 cites W2119838442 @default.
• W2463341441 cites W2120072658 @default.
• W2463341441 cites W2122304523 @default.
• W2463341441 cites W2123782548 @default.
• W2463341441 cites W2125010485 @default.
• W2463341441 cites W2132363654 @default.
• W2463341441 cites W2137137493 @default.
• W2463341441 cites W2139056292 @default.
• W2463341441 cites W2139614808 @default.
• W2463341441 cites W2154740756 @default.
• W2463341441 cites W2323325951 @default.
• W2463341441 doi "https://doi.org/10.18632/oncotarget.10264" @default.
• W2463341441 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5226487" @default.
• W2463341441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27356750" @default.
• W2463341441 hasPublicationYear "2016" @default.
• W2463341441 type Work @default.
• W2463341441 sameAs 2463341441 @default.
• W2463341441 citedByCount "10" @default.
• W2463341441 countsByYear W24633414412018 @default.
• W2463341441 countsByYear W24633414412019 @default.
• W2463341441 countsByYear W24633414412020 @default.
• W2463341441 countsByYear W24633414412021 @default.
• W2463341441 countsByYear W24633414412022 @default.
• W2463341441 countsByYear W24633414412023 @default.
• W2463341441 crossrefType "journal-article" @default.
• W2463341441 hasAuthorship W2463341441A5011351945 @default.
• W2463341441 hasAuthorship W2463341441A5011904150 @default.
• W2463341441 hasAuthorship W2463341441A5044943938 @default.
• W2463341441 hasAuthorship W2463341441A5047696571 @default.
• W2463341441 hasAuthorship W2463341441A5054743810 @default.
• W2463341441 hasAuthorship W2463341441A5068667427 @default.
• W2463341441 hasAuthorship W2463341441A5069905573 @default.
• W2463341441 hasAuthorship W2463341441A5074495073 @default.
• W2463341441 hasBestOaLocation W24633414411 @default.
• W2463341441 hasConcept C203014093 @default.
• W2463341441 hasConcept C2776090121 @default.
• W2463341441 hasConcept C2778690821 @default.
• W2463341441 hasConcept C2780007613 @default.
• W2463341441 hasConcept C502942594 @default.
• W2463341441 hasConcept C71924100 @default.
• W2463341441 hasConcept C86803240 @default.
• W2463341441 hasConcept C8891405 @default.
• W2463341441 hasConcept C90375314 @default.
• W2463341441 hasConceptScore W2463341441C203014093 @default.
• W2463341441 hasConceptScore W2463341441C2776090121 @default.

• next